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Chapter One: Introduction and Background 
 
The etiology of many neurodegenerative diseases is unknown, but a number of 
studies indicate that a combination of both genetic and environmental factors 
contribute to the progression of disease.  Metals are important in numerous biological 
processes in the brain.  Metal homeostasis is regulated through multiple mechanisms of 
transport, storage, and secretion, and breakdown of these processes have been 
implicated in the development of a number of neurodegenerative diseases including the 
loss of dopamine (DA) neurons in Parkinson’s disease (PD) [1,2].  The focus of these 
studies are to determine whether the genetically tractable nematode Caenorhabditis 
elegans (C. elegans) is sensitive to PD-associated metals Mn2+, Fe2+, Cu2+, and Al3+, 
whether these metals can induce dopamine neuron degeneration, and whether the C. 
elegans homologues to the human divalent metal transporter (DMT1) may contribute to 
metal induced neuropathology.  
 
Metals and Neurodegenerative Diseases 
Neurodegenerative diseases such as PD, manganism, Alzheimer’s disease (AD), 
and Wilson’s disease display an age-related loss of specific neurons, increased oxidative 
stress, and metal accumulation in surviving cells.  Exposures to high concentrations of 
metals such as Mn2+, Cu2+, and Al3+ can confer overlapping pathologies and exposures 
have been correlated with an increased propensity to develop these disorders.   
For example, Mn2+ and Cu2+ have been implicated in the development of PD, 
while Al3+ has been implicated in PD as well as AD, ALS, and Friedreich’s ataxia [7 - 9].  It 
has been suggested that the long half-life of Al3+ in numerous brain tissues, along with 
the long life of neurons contribute to its accumulation and elevated levels in 
neurodegenerative diseases [10].  A study of the hippocampus from patients with ALS 
and Parkinsonism-dementia of Guam supports Al3+ as a potential environmental factor 
contributing to increased accumulation of Al3+ in the neurofibrillary tangles [10, 11].   
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Parkinson’s Disease 
PD is the second most prevalent neurodegenerative disease after AD.  Early 
descriptions of PD were detailed by James Parkinson in 1817, which now is estimated to 
affect over 2% of the population over the age of 65 [22, 23].  The most common form of 
PD is called idiopathic or sporadic PD (~95% of the PD population), with the remaining 
portion of patients inheriting the disease directly due to genetic contributions [22, 24 - 
25].  Identification of genes involved in PD has provided insights into the molecular 
mechanisms involved in sporadic PD [25].  PD is generally considered a disease that 
slowly progresses over time, and there is no cure for the disease.  PD is characterized by 
the selective loss of dopamine (DA) neurons in the substantia nigra (SN) and often the 
presence of lewy bodies in surviving cells.  Lewy bodies are cytoplasmic inclusions of 
protein aggregates [26].  Clinical symptoms include resting tremor, bradykinesia, 
stiffness of limbs, and gait or balance problems [24].  Animals studies suggest that 
idiopathic PD results from a complex combination of genetic and environmental 
interactions in combination with the factors involved in aging [22, 23].  Central to PD 
research is the involvement of oxidative stress, and mitochondrial and proteasomal 
dysfunction [24, 25].  Postmortem studies of PD brains show increased oxidative stress, 
lipid peroxidation, as well as decreased mitochondrial complex I activity and glutathione 
levels in the SN [27, 28].   
Epidemiological studies suggest that metal exposure contributes to the 
development of PD.  A study by Zayed J. et al. 1990 suggests that occupational exposure 
to Mn2+, Fe2+, and Al3+ for a time period greater than 30 years increases the risk for PD.  
Postmortem analysis of brain tissues from Parkinsonism patients has shown an increase 
in total Fe2+, Zn2+, and Al3+ in the SN compared to control tissues [29 - 31].  In addition, a 
recent study suggests that Al3+ is one of the metals that significantly increase in early PD 
patient serum and may be a good indicator of disease progression [32].  Epidemiological 
studies have also suggested the potential involvement of occupational exposure to 
copper in the etiology of PD.  A study of Michigan counties by Rybicki B. et al. 1993 
suggests a statistically significant increase in PD death rates in areas with industries 
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using heavy metals.  These industries included paper and chemical production in 
addition to iron and copper mining.  Gorell J. et al. 1999 showed that chronic 
occupational exposure (>20 years) to Cu2+ or to dual combinations of lead, Fe2+, and Cu2+ 
was associated with PD.  
Environmental agents were ﬁrst recognized as potential risk factors in the 
development of PD with the identification of 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP), in a preparation of an illegally manufactured heroin-like 
drug.  MPTP-exposed individuals exhibited signs and symptoms of PD [39].  High 
exposures to the transition metal Mn2+ can cause a parkinsonism-like syndrome called 
manganism.  Manganism patients present with a similar loss of DA neurons in the SN, 
increased indicators of oxidative stress, motor disturbances, and often psychological 
disturbances [40, 41 - 45].  Mn2+ may also reduce DA release, and inhibit complex-I of 
the mitochondrial electron transport chain and increase the generation of reactive 
oxygen species (ROS) [46 - 50].   
PD does not naturally occur in species other than humans, therefore animal 
models are utilized to recapitulate various aspects of the human disorder [22, 34].  A 
model of PD is to expose DA neurons is 6-hydroxydopamine (6-OHDA), a hydroxylated 
analogue of DA.  This model of PD was first proposed over 40 years ago, and is a well-
studied mammalian toxicant model due to its ability to induce specific DA neuron 
degeneration both in vitro and in vivo [35, 36].  The specificity of 6-OHDA for causing 
degeneration in DA neurons is attributed to its ability to be transported into the cells by 
the DA transporter (DAT).  Studies have shown that DAT antagonists like imipramine or 
nisoxetine or mutations that render DAT non-functional are able to inhibit 6-OHDA 
effects [37, 38]. 
 
Alzheimer’s Disease 
 AD is the most common neurodegenerative disorder, characterized by the 
development of extracellular plaques consisting of aggregated insoluble amyloid-β 
polymer, intracellular neurofibrillary tangles, and a selective loss of neurons in the 
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hippocampal and cerebral cortical regions [7, 51].  The role of Al3+ in AD is still 
controversial and there are many studies supporting as well as refuting the involvement 
of the metal.  In the 1960’s the “aluminum hypothesis” was first proposed based on 
studies that found Al3+ injections induce neurofibrillary tangle-like lesions, increased Al3+ 
levels in AD patients, and increased prevalence of AD in regions with high Al3+ in the 
drinking water [52 - 54].  It has been suggested that many of these initial studies were 
inaccurate due to morphological differences in neurofibrillary changes, potentially 
contaminated brain samples, or inconclusive data sets [55, 56].  Another hypothesis 
suggests metals such as Al3+, Cu2+, and Fe2+ can alter oligomerization and induce 
conformational changes that result in amyloid-β polymer-induced neurotoxicity [7, 51].   
Epidemiological data suggest Al3+ exposure increases memory deficits in AD patients [7].  
Fe2+ and Cu2+ are consistently found at high levels in the brain regions most prone to 
AD-associated neurodegeneration [14, 15].  Some studies suggest that the source of 
oxidative stress in the AD brain may come from the generation of ROS via molecular 
oxygen and Cu2+ [58].  Amyloid precursor protein has also been shown to reduce Cu2+ to 
Cu+ generating hydrogen peroxide that can form hydroxyl radicals via the Fenton 
reaction [16].  In C. elegans, aggregation of amyloid-β protein is accelerated by exposure 
to Cu2+, and the aggregation is inhibited by the Cu2+ chelators, histidine or clioquinol 
[59].  Hyperphosphorylated tau, a significant component of neurofibrillary tangles, has 
been shown to bind Cu2+causing protein aggregation that may increase neuronal 
oxidative stress [60]. 
 
Menkes and Wilson’s Diseases 
Menkes disease and Wilson’s disease are neurodegenerative diseases in which 
mutations in Cu2+ transport can cause altered brain development, defective synthesis of 
collagen, increased ROS and neurological problems [20, 40, 61, 62].  In Wilson’s disease 
a mutation in a Cu2+ transporter results in abnormal Cu2+ accumulation and parkinsonian 
like symptoms [63, 64].  Unbound Cu2+ can catalyze the Fenton and/or Haber-Weiss 
reactions, which can result in the generation of the highly reactive and damaging 
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superoxide and hydroxyl radicals [16, 20].  Cu2+ can also be toxic due to its binding to 
protein sulfhydryl groups, resulting in enzyme inactivation or altered protein folding 
which contributes to inclusion body formation.  Exposure to toxic levels of Zn2+ has been 
shown to alter copper homeostasis by upregulating metallothioneins which can increase 
Cu2+ elimination.  Imaging studies have shown some Wilson’s disease patients to have 
severe loss of striatal DAT and significantly reduced integrity of both pre- and post- 
synaptic DA neuronal regions [66, 67].  In addition, Long-Evans Cinnamon rats, which are 
used as a rodent model of Wilson’s disease, have shown increased indicators of 
oxidative stress in the brain regions that typically accumulate Cu2+ due to the disease 
[67, 69]. 
 
Aluminum 
Aluminum is the most abundant metal in the earth’s crust and the third most 
abundant element in the environment [70, 71].  Humans are primarily exposed to Al3+ 
through food or environmental contamination.  Al3+ also comes in direct contact with 
humans as it is used in pharmacological products like antacids and antiperspirants [74].  
Al3+ is a non-essential metal ion, and exposure to high concentrations of Al3+ has been 
shown to contribute to toxicity across many organisms [31, 70, 75].  The proximal 
intestine appears to be the primary site of Al3+ absorption by calcium channels and 
sodium transporters, while transferrin and urine are potentially the primary routes for 
excretion [71].  Al3+ has a high propensity to form hydroxyl complexes in an acidic 
environment [154].  Al3+ can cross the blood brain barrier, but the mechanism of 
transport has been controversial.  Studies have suggested Al3+ may be transported by 
transferrin receptor-mediated endocytosis or through a glutamate transporter [7, 71].  
Al3+ has also been shown to alter mitochondrial function by interfering with ATP 
production and reducing antioxidant defenses [175, 190].  In addition, Al3+ has been 
suggested to alter DA neurotransmission by altering membrane integrity and dopamine 
receptor density, as well as decreasing DA levels [72, 75, 76]. 
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Copper 
In biological systems Cu2+ is an essential cofactor for many enzymes and is 
utilized in electron transport [1, 77].  The primary source of Cu2+ exposure is through 
food or environmental contamination [77, 78]. After being absorbed through the GI 
tract, Cu2+ is transported by albumin.  Cu2+ in the liver is bound by metallothionein, and 
secreted into plasma or excreted in the bile [79, 80].  Some of the critical enzymes 
requiring Cu2+ are involved in mitochondrial respiration, peptide hormone production, 
pigmentation, neurotransmitter metabolism, and Fe2+ transport.  These enzymes 
include cytochrome c oxidase, Cu/Zn superoxide dismutase, tyrosinase, dopamine β-
hydroxylase, and metallothionein [20, 79].  Cu2+ is also one of the few metals within the 
cell that causes increased oxidative stress with either excess accumulation or deficiency 
[81].  Some studies have suggested that DMT1 and the high affinity Cu2+ transporter, 
CTR1 , may play a significant role in Cu2+ transport across the plasma membrane [91]. 
 
Oxidative Stress 
The nervous system is particularly sensitive to oxidative damage due to the high 
rate of oxygen consumption, relatively high Fe2+ levels, and concentration of oxidizable 
polyunsaturated fatty acids in neuronal membranes [29].  Understanding how oxidative 
imbalance contributes to DA neuron sensitivity in diseases such as PD could provide 
insight into the etiology of the disease [83, 84].  Studies have shown factors which 
contribute to DA neuron specific increased oxidative stress include large stores of Fe2+, 
α-synuclein accumulation, and easily oxidized DA [85 - 87].  PD patients present with 
increased oxidative stress and lipid peroxidation, decreased levels of glutathione (GSH) 
and mitochondrial complex I activity, and the presence of dopamine quinones [27, 30, 
88]. 
Glutathione synthesis is one of the cell’s most important antioxidant responses 
to scavenge free radicals [46, 92].  Post mortem studies of PD brains have shown a 
decrease in GSH levels in the SN, and a correlation between PD severity and GSH deficit 
[29, 93].  Loss of GSH has also been associated with impaired mitochondrial electron 
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transport chain function [94].  As a major antioxidant in the brain GSH has multiple 
functions including scavenging of superoxide and hydroxyl radicals [95].  GSH serves as 
an electron donor for glutathione peroxidase, and as a cofactor for glutathione s-
transferases (GSTs).  Toxic exposure of Al3+ is suggested to inhibit mitochondrial NADP-
isocitrate dehydrogenase, decrease GSH, and decrease GSH peroxidase and catalase 
activities effecting cellular oxidative stress levels [96 - 98].  Exposure to high Cu2+ levels 
significantly decreases total glutathione levels [1, 101].  In addition, in vitro studies 
suggest that exposure to Cu2+ inhibit GST and alter glutathione peroxidase activity [102]. 
DA can be degraded by monoamine oxidase to generate hydrogen peroxide, or 
can contribute to the formation of superoxide and quinones that can cause 
denaturation of proteins, lipid peroxidation, and DNA damage as depicted in Figure 1 
[83].  A number of studies indicate that DA in the presence of the transition metals Fe2+, 
Cu2+, and Mn2+ can catalyze production of free radicals [20, 40, 92].  While Al3+ is not a 
redox-active metal, it has been shown to facilitate pro-oxidant activities like Fe2+-
induced lipid peroxidation, oxidation of NADH, and formation of hydroxyl radical [99].  
Neuromelanin is a redox-active brain pigment associated with neurodegeneration in the 
DA neurons in the SN of PD patients [73, 103].  In vitro studies have also shown that Al3+ 
can facilitate Fe2+/Cu2+ oxidation of DA to neuromelanin.  Once formed, neuromelanin is 
capable of binding metals such as Al3+ resulting in increased lipid oxidation due to the 
formation of an Al-·O2
- complex with increased oxidant capacity [73, 99].  Studies have 
also shown Al3+ co-exposure with the PD toxicants 6-OHDA or MPTP increases free 
radical generation, DA neuron degeneration, lipid peroxidation, and DA turnover [96, 
104-107]. 
 
Divalent metal transporter 
The divalent metal transporter (DMT1), or natural resistance-associated 
macrophage protein 2 (Nramp2), is a proton-coupled membrane transporter with 12 
transmembrane domains that is expressed in most tissues [108].  The transporter has 
been shown to transport divalent cations such as Fe2+, Mn2+, Cu2+, Zn2+, and lead [14, 
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109, 110].  DMT1 family members share a consensus transport sequence located 
between transmembrane domain 8 and 9 that is involved in metal translocation across 
the membrane [46].  Homologues of human DMT1 have been identified across multiple 
species including plants, yeast, C. elegans, and many vertebrates [46, 111].  In 
mammalian systems, DMT1 has been identified to function primarily in Fe2+ uptake and 
distribution [84].  In yeast and C. elegans, three homologues to DMT1 have been 
identified and are called SMF-1, SMF-2, and SMF-3 [46, 111].  In yeast the cellular 
localization of the three SMF proteins may depend on the extracellular environment 
[111].  For example, Portnoy M.E. et al. 2000 found when Mn2+ was added to growth 
media, both Smf1p and Smf2p were targeted to the vacuole for degradation.  In 
contrast, Mn2+ starvation caused Smf1p expression within the plasma membrane, while 
Smf2p localized to intracellular vesicles.  Salazar J. et al. 2008 showed protein extracts 
from the SN of PD patients had an increase in the Fe-responsive isoform of DMT1 and a 
decrease in non-Fe responsive DMT1 isoform, compared to SN tissues from patients 
without PD.  In addition, a mutation in DMT1 which impairs Fe2+ transport was able to 
protect against both MPTP and 6-OHDA-induced DA neuron degeneration in mice [84].  
PARK2, an E3-ligase contributing to protein proteasomal degradation, has been 
identified as one of the genetic factors resulting in early-onset PD.  Mutation in the 
PARK2 gene results in the selective loss of DA neurons in the SN [5].  There is additional 
evidence which suggests mutation may also alter DA homeostasis and contribute to late 
onset of PD [6, 12].  A recent in vitro study has shown that PARK2 can also selectively 
regulate DMT1 expression [113].  This study suggested that overexpression of PARK2 
not only reduces transport of Mn2+, but also decreases expression of DMT1.  This 
suggests an additional regulatory mechanism for DMT1 and further implicates DMT1’s 
potential role in DA neuron degeneration.   
 
C. elegans as a model system 
The nematode C. elegans is a powerful model system to explore the cellular and 
molecular basis of PD-associated DA neuronal death [46, 116, 117].  C. elegans have 
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been used as an important model system for biological research in the fields of 
genomics, cell biology, neuroscience and aging [118].  Its small size, rapid development, 
large brood size, and a food source primarily of bacteria lend to the ease and low cost of 
laboratory culture.  The adult hermaphrodite is approximately 1mm in length and can 
progress from embryo to adult within 3 days [118].  Other advantages include its 
transparent body, along with a well-defined cell pattern and nervous system [119].  
There are two sexes of C. elegans, a self-fertilizing hermaphrodite and a male.  Each 
adult hermaphrodite typically produces 300-350 progeny, but this is only limited by the 
number of sperm produced.  Male fertilization can increase the number of oocytes 
fertilized to closer to 1000 [120].  Males naturally arise infrequently (0.1%), but this 
frequency can be increased by environmental stresses or through genetic mutations 
[121]. 
The self-fertilization of the hermaphrodite allows homozygous animals to 
generate genetically identical progeny, and male mating allows for the isolation and 
maintenance of mutant strains along with the addition of new mutations [119].  Another 
advantage of C. elegans as a model system is the relatively short period of time to 
generate mutant strains.  Confirmation of new mutants and genetic crosses can be 
quickly performed through whole animal polymerase chain reaction (PCR), termed 
single worm PCR [122].  An alternative to generating genetic knockout lines is 
incorporating genetic knockdown through RNA-mediated interference (RNAi) [115].  The 
first evidence that double stranded RNA could cause gene silencing came from C. 
elegans studies by Andy Fire’s and Craig Mello’s laboratory [124].  Although neurons are 
largely insensitive to RNAi, a mutation in a RNA polymerase gene, rrf-3, increases the 
efficacy of RNAi-mediated genetic knockdown in most neurons including the DA 
neurons [127, 128]. 
In humans, DA, in addition to being essential for coordinating body movements, 
is involved in addiction, motivation, reward, and reinforcement [129].  Loss of DA 
neurons and depletion of DA in the basal ganglia results in the movement abnormalities 
associated with PD [130].  DA synthesis is dependent on the essential amino acid 
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tyrosine.  Tyrosine is metabolized by tyrosine hydroxylase (TH) to L-3,4-
dihydroxyphenylalanine (L-DOPA), which is then decarboxylated to DA by DOPA 
decarboxylase [130, 132].  Following neurotransmission, DA inactivation involves 
reuptake of DA by the presynaptic DAT where it is then metabolized or repackaged for 
storage.  DA is metabolized by catechol-O-methyl transferase and monoamine oxidase 
[130].  Dopamine synthesis and metabolism are very tightly regulated as DA alone is 
very reactive, and degradation results in the generation of free radicals [92].  C. elegans 
have similar molecular components as mammalian systems that are involved in DA 
synthesis, packaging, signaling, transport, and degradation [(Figure 1), 38, 115].   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1:  Dopamine synthesis, metabolism, and DA free radical production in mammals and C. elegans.  C. 
elegans genes in red.  DA, dopamine; TH, tyrosine hydroxylase; GTPCH, GTP cyclohydrolase; AAAD, 
aromatic L-amino acid decarboxylase; MAO, monoamine oxidase; DOPAC, 3,4-dihydroxyphenylacetic acid; 
COMT, catechol-O-methyl transferase; HVA, homovanillic acid; VMAT, vesicular monoamine transporter; 
DAT, dopamine transporter; GSH-Px, glutathione peroxidase; H2O2, hydrogen peroxide; ·O2
-
, super oxide 
radical; ·OH, hydroxyl radical [38, 92].   
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  While DA is not required for C. elegans viability, DA signaling is involved in the 
mechanosensation of food, egg-laying, defecation, movement, and mating [133 - 136]. 
C. elegans have 302 neurons in the adult hermaphrodite and 383 neurons in the 
adult male [118, 121].  Hermaphrodites have eight DA neurons and the males have 
three additional pairs of DA neurons in the tail.  These neurons can be easily seen in vivo 
under a fluorescent dissecting scope when the green fluorescent protein is expressed 
behind the DAT promoter (Figure 2) [38].  The nematode head contains four cephalic 
cells (CEPs) and two anterior deirids (ADEs) (Figure 2).  The CEP dendrites extend from 
the cell body, which is near the nerve ring, to the tip of the nose [115].  The tail also 
contains two posterior deirids (PDEs) near the vulva (refer to [115] for image). 
 
 
Figure 2:  Dopamine neurons in the head region of an adult hermaphrodite C. elegans.  Confocal images of 
BY250 strain which expresses GFP behind the dat-1 promoter showing the 6 DA neurons in the head 
region, four CEPs and two ADEs.  The thick arrow points to cell bodies, while the thin arrow points at the 
appropriate dendritic processes CEP and ADE from left to right.  Photos taken 72 hours after L1 stage and 
were captured using confocal microscopy (Zeiss LSM 510 microscope).  Scale bar indicates 20 μm. 
  
A 
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Chapter Two: Experimental Data 
 
The molecular mechanisms involved in PD and manganism is largely unknown, 
but numerous studies indicate increased DA neuron cell death is a common factor [22, 
24].  As previously introduced excess exposure to environmental metals such as Mn2+, 
Fe2+, Al3+, or Cu2+ have been shown to induce cell-death and increase oxidative stress 
which has been implicated in PD.  In addition, vertebrate evidence suggests DMT1 
transports ions such as Mn2+, Fe2+, or Cu2+ into DA neurons [84, 112].  Therefore I 
propose that exposure to Mn2+, Fe2+, Al3+, or Cu2+ can induce DA neurodegeneration and 
DMT1 contributes to increased DA neuron sensitivity.  To explore this hypothesis, I use 
the powerful animal model C. elegans to evaluate animal vulnerability, changes in 
oxidative stress, DA neuron degeneration, and contribution of DMT1 homologues SMF-
1, SMF-2, and SMF-3 after metal toxicant exposure. 
 
Materials and Methods 
C. elegans strains and maintenance - Nematode Growth Medium (NGM) or 8P plates 
containing bacterial lawns of either OP-50 or NA-22, respectively, were used to grow C. 
elegans strains at 20˚C consistent with standard methods [137, 140].  OP-50 is a uracil 
auxotroph E. coli whose growth is limited on NGM plates to enable easier observation 
[141], while NA-22 E. coli grow in very thick layers and are an optimal food source for 
large quantities of worms when fed on 8P plates [13].  The C. elegans strains used in 
these experiments are listed in Table 1.  Homozygotes from genetic crosses were 
verified using single worm PCR [122].  Frozen stocks (-80˚C freezer) were generated by 
mixing a largely L1 population of worms as previously described [141].  
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Table 1: C. elegans experimental strains used 
Strain name Genotype Strain name Genotype 
N2 Wild type Bristol RJ907 Pdat-1::GFP;smf-1(eh5)X 
IG6 smf-1(eh5) X RJ905 Pdat-1::GFP;smf-2(gk133)X 
VC171 smf-2(gk133) X RJ906 Pdat-1::GFP;smf-3(ok1035)IV 
RB1074  smf-3(ok1035) IV RJ928 Pdat-1::GFP;rrf-3(pk1426) II 
BY250 Pdat-1::GFP BY200 Pdat-1::GFP; rol-6 
  BY215 Pdat-1::GFP;rol-6;dat-1(ok157)III 
 
Whole-animal vulnerability assay - Gravid adults were collected and rinsed 3 times with 
dH2O, and eggs were harvested after hypochlorite treatment following standard 
protocols [38, 117].  Eggs were then incubated in M9 buffer, a standard C. elegans 
laboratory solution containing essential salts necessary for eggs to continue 
development to the L1 stage, on a rocker for 18 hours at room temperature.  After 
which the synchronized population of L1 animals were rinsed again 3 times with dH2O 
and counted to determine the approximate number of worms per μl using a Zeiss 
dissecting microscope.  L1 animals (30 - 50) were placed on NGM plates with OP50 
bacteria +/- various concentrations of metal solutions.  These solutions included MnCl2 
[10 - 30 mM] (Fisher Scientific, Fair Lawn, NJ), CuCl2 [50 - 500 μM] (Alfa Aesar, MA), AlCl3 
[.1 - 1 mM] (Fisher Scientific, UK), and FeCl2 [100 - 500 μM] (Sigma Aldrich, St. Louis, 
MO), and were added to autoclaved NGM agar prior to pouring the 60 mm plates.  L1 
animals were grown for 72h at 20°C and assayed for viability.  Animals were considered 
to be alive when moving or when responding to a gentle touch with a metal pick on the 
nose [142].  All experiments were performed at least in triplicate, the results were 
reported as mean +/- S.E.M., and statistical analysis was performed using GraphPad 
Prism5.   
RNA extraction and cDNA synthesis - After treatment with AlCl3 for 30 min and 
recovery on NGM plates for 48 hrs., the worms were washed from the plates and rinsed 
with dH2O at least 3 times or until the dH2O appeared clear.  Worm pellets were then 
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resuspended in Trizol (1 ml worms/100 μl Trizol).  Total RNA was extracted as previously 
described, but with minor modifications [143].  Chloroform was used to denature and 
separate proteins and lipids from the sample, and isopropyl alcohol was added to 
remove the DNA and allow RNA precipitation.  The RNA pellet was washed with 75% 
ethanol, allowed to dry, and then resuspended in RNase-free water.  A small volume 
from each sample was then diluted to measure the RNA concentration, while the 
remaining portion of the sample was stored at -80°C.  RNA concentrations were 
determined using a ND-1000 spectrophotometer (Nanodrop Technology, Wilmington, 
DE).  cDNA synthesis was followed according to manufacturer’s instructions (Bio Rad, 
CA).  The cDNA was purified using dH2O and Microcon YM30 filters (Millipore corp., 
Bedford, MA), and the concentration determined using the ND-1000 
spectrophotometer.  cDNA sample were stored at -20°C. 
Real-time PCR measurements - Primers were designed with Primer3 software.  All qRT-
PCR measurements were determined relative to glyceraldehyde-3-dehydrogenase 
(GAPDH) as its expression does not change as a result of exposures (unpublished lab 
results). The primers in Table 2 were used to determine changes in gene expression of 
the following genes: 
Table 2: Primers used to determine changes in gene expression   
Gene Forward primer 5’ - 3’ Reverse primer 5’ - 3’ 
Gapdh GAAACTGCTTCAACGCATCA CCTTGGCGACAAGAAGGTAG 
smf-1 GTGGGTTTTGCTCTCAGCTC TGGCAATTGCTGTTCCAATA 
smf-2 GCACTGGTTGGCTGATTTTT GGAGCATCCAGTTCCAGTGT 
smf-3 GGAGTGCGAAAGTTTGAAGC TTGACAAGTGCCGAGTGAAG 
 
The real-time reaction was performed using a 2X SYBR Green PCR master mix which 
included SYBR Green, cDNA at 25 ng/μl, and dH2O.  The PCR master mix with the cDNA 
of interest and primers were added to the appropriate wells within a 96-well plate.  
Negative controls were added to wells that contained the entire PCR master mix minus 
the cDNA.  The ABI Prism 7500 sequence detection system (Applied Biosystems, 
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Warrington, UK) was used to detect the quantity of PCR product.  A CT value indicates 
the cycle number that the fluorescence passes the threshold determined for SYBR Green 
fluorescence.  Studies were performed in triplicate and the ΔCT was calculated for each 
exposure condition based on the difference in CT value for control and GAPDH.  The 
ΔΔCT was calculated by subtracting the control ΔCT from the AlCl3 ΔCT.  Fold change was 
then calculated based on 100% efficiency (2^( ΔΔCT)). 
Toxicant exposures - My initial studies determined DA neurons were more sensitive to 
30 min exposure to MnCl2 when exposed in the first larval stage (L1) as compared to 
animals exposed at the fourth larval (L4) stage or adult stage.  The life cycle of C. elegans 
begins with the embryonic stage, progresses through four larval stages, and then 
reaches adulthood [118].  To eliminate additional potential variability in results due to 
the developmental stage of animal exposed, I began each of my experiments with a 
population of animals all at the L1 stage by using a common C. elegans laboratory 
procedure called synchronization [117].  To determine the appropriate recovery time to 
evaluate DA neuron degeneration after MnCl2 exposure, I evaluated the number of 
animals that displayed DA neuron cell death at multiple time points.  I found that after 
30 minute exposure to 50 mM MnCl2, the number of animals that displayed DA neuron 
degeneration was greater 72 hours post exposure compared to 48 hours (Figure 3).  I 
therefore decided to use the 72 hour time point to examine DA neurons in all future 
experiments. 
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Figure 3:  C. elegans DA neuron degeneration increases 72 hours post-MnCl2 exposure.  A synchronized 
population of L1 BY250 animals was exposed for 30 min to dH2O + 50 mMnCl2, and then recovered on 
NGM plates for 48 or 72 hours prior to evaluation of DA neuron degeneration. *p > .05 as determined by 
two-tailed t-test comparing MnCl2 exposure groups at each time point.   
 
Samples of gravid adults were collected from plates by washing with dH2O, 
spinning at 2500 rpm for 2 min, and removing the supernatant and repeating the 
washes until all bacteria was removed from the sample using standard protocols [38, 
116].  Then animals were synchronized using hypochlorite treatment and incubated on a 
rotating plate at room temperature for 18 hours in M9.  L1 stage worms were then 
washed at least 3 times with dH2O and counted using a dissecting microscope.   
Acute exposures of L1 animals were set up with 10 worms/μl and incubated with 
varying concentrations of MnCl2, CuCl2, AlCl3, or FeCl2, added to dH2O in 1.5 ml 
centrifuge tubes [116].  Samples were incubated for 30 min at room temperature with 
gentle mixing every 10 min throughout exposure.  After exposure, each sample was 
spun down at 2500 rpm for 2 min, supernatant removed, and the rinse repeated 3x with 
dH2O.  Animals were then placed onto NGM plates seeded with OP50 bacteria and 
allowed to recover for 72 hours at 20°C.  Between 50 - 60 worms were then picked onto 
microscope slides containing 2% agarose pads and immobilized using 2% sodium azide.  
Animals were scored for DA neuron degeneration under the fluorescent microscope 
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(Leica MZ 16FA, Switzerland).  DA neuron degeneration was considered positive if there 
was not a continuous GFP signal along the CEP dendrite [38].  Figure 4 A & C shows an 
example of animals without and with degeneration respectively.  For exposures with 
more than one toxicant, the first 30 min exposure remained the same as described 
above, animals were then washed at least 3x in dH20 using standard protocols and 
resuspended in the second solution +/- toxicant at 10 worms/μl and exposed for 30 
minutes.  Animals were allowed to recover, prepared for imaging, and then scored as 
described above.  
For chronic exposures, synchronized populations of L1 animals were plated on 
NGM containing varying concentrations of MnCl2, FeCl2, AlCl3, or CuCl2.  The toxicants 
were added to the NGM agar prior to pouring the plates per standard protocols [116].  
OP-50 bacteria was spread on each of the metal toxicant plates and allowed to grow as 
previously described [116].  After 72 hours of toxicant exposure, DA neuron integrity 
was evaluated as described above.  Each of the experiments was performed at least in 
triplicate, the results are reported as means + S.E.M., and statistical analysis was 
performed using GraphPad Prism5.  
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Figure 4.  PD-associated toxicants MnCl2 or 6-OHDA induces DA neuron degeneration in C. elegans.  L1 
BY250 animals were exposed dH2O +/- 50 mM MnCl2 or 1% dimethyl sulfoxide (DMSO) +/- 5 mM 6-OHDA 
for 30 min and then images were taken 72 hrs. after exposure. Images are displayed as fluorescent and 
corresponding DIC image of animals exposed to A & B) dH20 C & D) 50 mM MnCl2 E &F) 1% DMSO in dH2O 
G & H) 5 mM 6-OHDA.  Long arrows point to representative CEP process damage, short arrow points to 
representative CEP cell body damage.  Images are representative of toxicant-induced DA neuron 
degeneration and were captured using confocal microscopy (Zeiss LSM 510 microscope).  Scale bar 
indicates 20 μm.   
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Mitochondrial Membrane Potential Analysis - Tetramethylrhodamine ethyl ester 
perchlorate (TMRE, Sigma Aldrich, St. Louis, MO) is a voltage-sensitive fluorescent 
indicator that accumulates in active mitochondria and was used to determine changes in 
mitochondrial membrane potential [144].  Acute exposure of L1 stage worms for 30 min 
to 100 μM AlCl3 was carried out similar to described above, then animals were placed on 
NGM plates containing 0.1 μM TMRE and incubated in the dark [144, 145].  After 48 
hours, 20 - 30 animals were picked onto slides with 2% agarose pads and immobilized 
with 2% levamisole.  Levamisole has been identified to cause muscle paralysis in C. 
elegans due to the prolonged activation of nicotinic acetylcholine receptors in the body 
wall muscles [18].  Pictures of the head region of each animal were captured using a 
Leica MZ 16FA fluorescent microscope with a Texas Red filter.  The change in membrane 
potential was calculated based on changes in average pixel intensity using Image Pro 
Plus v6.2 software (Media Cybernetics, MA).  Each exposure condition was evaluated in 
triplicate. 
ROS Analysis - ROS was determined using 2,7-dichlorodihydrofluorescein diacetate (H2-
DCF-DA)-associated fluorescence [46, 146, 147].  A synchronized population of worms 
was exposed to 1 μM CuCl2 for 30 min and rinsed 3x with dH2O, followed by 
resuspension in M9 at a concentration of 50,000 worms/ml.  A 96-well plate was used to 
set up four replicates in different wells of each control and experimental condition.  
Experimental conditions included 50 μl of resuspended worms from either the dH2O or 
1 μM CuCl2 groups in addition to 50 μl of 100 μM H2-DCF-DA.  Control wells were set up 
on each plate in triplicate and included 50 μl of resuspended worms from each 
experimental condition with 50 μl of M9 instead of H2-DCF-DA, and 50 μl of H2-DCF-DA 
with 50 μl of M9 instead of resuspended worms.  Total ROS was determined based on 
emitted light at 520 nm on a Tecan Spectrafluor Plus spectrophotometer [46, 147, 148].  
The 96-well plate was covered and placed on a shaker for 60 min and then read again.  
The final values were normalized with the appropriate control wells and compared 
between experimental conditions.  This assay was performed in triplicate.  
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RNA Interference - RNAi-sensitive NL2099 rrf-3(pk1426) nematode strain was crossed 
with BY250, and homozygosity was determined by single worm PCR [46, 127].  The new 
strain was named RJ928.  RNAi experiments were carried out on NGM plates seeded 
with HT115 (DE3), an RNase III-deficient Escherichia coli strain carrying L4440 vector 
with the gene fragment (aco-1, gst-1, ftn-1, or ftn-2) (GeneService, Source BioScience, 
PLC, Nottingham, UK) or empty vector (Addgene, Cambridge, MA) with the addition of 1 
mM isopropyl 1-thio-β-D-galactopyranoside [127].  RJ928 L1 stage worms from a 
synchronized population were transferred onto the RNAi plates and allowed to grow 
until gravid.  Eggs were harvested and synchronized as above and the second generation 
L1s were then placed back onto the RNAi plates.  After approximately 46 hours, 
between 50 - 100 gravid adults were transferred to fresh RNAi plates and allowed to lay 
eggs for 5 hrs.  Adults were then removed from the plate and approximately 9 hours 
later, the recently hatched L1s were exposed to 100 μM AlCl3 for 30 min.  After the 
exposure, L1 animals were washed and allowed to recover on the appropriate RNAi 
plates for 72 h and then evaluated for DA neuron degeneration as previously described 
[46]. 
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Results 
Chronic metal exposure 
Prior vertebrate studies have shown that exposure to concentrations, as high as 
2.5 mM and 6 mg/kg/day, of Mn2+ result in metal accumulation in the striatum in 
addition to animal and cell death [19, 57].  C. elegans relatively impermeable cuticle 
may block entry of compounds, thereby requiring higher exposure concentrations.  Our 
lab previously showed 30 min exposure to 50 mM MnCl2 results in C. elegans 
accumulated Mn2+ tissue concentrations similar to vertebrate systems [46].  In order to 
determine if Mn2+ exposure affects the viability of animals after long term exposure, I 
exposed worms to varying concentrations of Mn2+.  Synchronized BY250 L1 animals 
were added to NGM plates with varying levels of MnCl2.  Animal viability was 
determined after 72 hrs.  As can be seen in Figure 5, Mn2+ exposure concentration 
affects animal viability in a concentration-dependent manner, with the IC50 = 12.97 mM 
MnCl2.  IC50 was calculated using ReaderFit software (Hitachi Solutions America) using a 
4 parameter logistic nonlinear regression model.  
 
Figure 5:  72 hour exposure to Mn
2+ 
exhibit increased animal death. Graph shows animal viability after 72 
hour exposure to mM +/- MnCl2.  Data was analyzed using one-way ANOVA followed by Dunnett’s 
multiple comparison test (** > p .01, *** > p .001). 
 
Epidemiological studies have suggested occupational exposure of greater than 
20 years to metals can increase the onset of PD [10, 29], and a pathological hallmark of 
both PD and manganism is the loss of DA neurons in the SN.  To test the hypothesis that 
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chronic exposure to metals associated with PD may contribute to DA neuron 
degeneration, synchronized BY250 L1 animals were placed on NGM plates with varying 
concentrations of MnCl2, FeCl2, AlCl3, or CuCl2 and DA neuron degeneration was 
evaluated after 72 hr.  Figure 6 shows that chronic exposure to MnCl2, FeCl2, AlCl3, or 
CuCl2 confers DA neuron degeneration.  Animals exposed to FeCl2, AlCl3, or CuCl2 did not 
exhibit any changes in animal viability at the concentrations tested. 
 
Figure 6:  MnCl2, FeCl2, AlCl3, and CuCl2 induce significant DA neuron degeneration after 72 hour exposure.  
Shown are mM exposures in mean values + S.E.M. of at least three individual replicates.  p values (*** p < 
.001 and ** p < .01) were calculated using t-test analysis for panels A,B, D and using an one-way ANOVA 
followed by Dunnett’s multiple comparison test for panel C. 
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DMT1 transports Fe2+ into vertebrate DA neurons and confers Fe2+-induced cell 
death, and our studies have recently shown that the DMT1 homologue, SMF-1, localizes 
to C. elegans DA neurons [14, 46, 109, 110].  I utilized strains created by our lab for 
previous work with Mn2+ [46] which were verified to express GFP fusion behind the DAT-
1 promoter and have a mutation in one of the SMFs.  The strain RJ907 (listed as Δ smf-1 
in figures) contains a 2063-bp deletion in smf-1 which results in a truncated protein 
containing only the first 6 transmembrane domains.  This mutation is predicted to be a 
non-functional protein, based on the consensus transport sequence being deleted [46, 
65].  The strain RJ905 (listed as Δ smf-2 in figures) contains a 448-bp deletion in smf-2 
which spans the start codon and the first 3 transmembrane domains, and likely results 
in a non-functional protein [46, 65].  The strain RJ906 (listed as Δ smf-3 in figures) 
contains an 1800-bp deletion spanning transmembrane domains 1-8.  This mutation 
likely results in a non-functional protein due to lack of transmbrane domain 8, in 
addition loss of transmembrane domain 6, which has been shown to impair symporter 
activity [65].  In order to determine if Fe2+-induced DA neuron degeneration is 
dependent on any of the SMFs, I evaluated DA neuron integrity following acute and 
chronic exposures to Fe2+ in animals with mutations in the transporters.  Figure 7 shows 
that after both 72 hour and 30 min exposures to 500 μM FeCl2, SMF-1 significantly 
contributes to Fe2+-induced DA neuron degeneration in C. elegans.  All strains exposed 
to dH2O (wild type (WT), Δ smf-1, Δ smf-2, and Δ smf-3) did not exhibit DA neuron 
degeneration and therefore were not included in Figure 7. 
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Figure 7:  SMF-1 significantly contributes to FeCl2-induced DA neuron degeneration after both 72 hour and 
30 min exposure.  L1 animals were exposed to 500 μM FeCl2 and then evaluated at the end of the 72 hrs. 
for degeneration.  WT (BY250) and Δ smf-1 (RJ907) exposed for 72 hr. (panel A) or WT, Δ smf-1 , Δ smf-2 
(RJ905), and Δ smf-3 (RJ906), were exposed for 30 min (panel B).  Data was analyzed using t-test 
compared to WT (*** p < .001) in panel A and using one-way ANOVA followed by Dunnett’s multiple 
comparison test (*p < .05) in panel B. 
 
Aluminum 
It has not been established that Al3+ is an essential metal ion, but exposure to 
high concentrations has been shown to contribute to toxicity and cell death in many 
species [154 - 156].  In vitro studies have shown that even though it is not a redox-active 
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metal, Al3+ can facilitate increased reactive oxygen species by interacting with other 
metals to increase oxidation of DA or lipids [73, 99].  Therefore to test the hypothesis 
that AlCl3 exposure increases oxidative stress in C. elegans, a synchronized population of 
L1 animals was exposed for 30 min to 100 μM AlCl3, similar to previous studies [46].  
Worms exposed to dH2O + 100 μM AlCl3 did not result in any changes in animal 
vulnerability (data not shown).  Animals were placed on TMRE plates for 48 hr. and 
mitochondrial membrane potential in the head region was evaluated.  A brief exposure 
to a low Al3+ concentration significantly reduces mitochondrial membrane potential in 
the head relative to control animals.  This supports previous vertebrate data and 
suggests Al3+ may impair mitochondria function in C. elegans (Figure 8). 
 
Figure 8:  Acute Al
3+
 exposure significantly decreases mitochondrial membrane potential in the head 
region of worms. Animals were allowed to recover on TMRE plates for 48 hours after 30 min exposure + 
100 μM AlCl3. * p < .05 as determined by t-test of toxicant exposure to control. 
 
Environmental exposure to low levels of metals including Fe2+, Mn2+, Cu2+, and 
Al3+ have been shown to induce oxidative stress, which is a contributing factor of 
neurodegenerative diseases.  In order to determine whether a brief acute exposure to 
Al3+ causes DA neurodegeneration, I evaluated DA neuron integrity following a 30 min 
exposure to low concentrations of Al3+.  As seen in Figure 9, acute sub lethal exposure to 
Al3+ induces significant DA neuronal death.  
50
55
60
65
70
75
80
85
90
95
100
0 100
M
e
an
 In
te
n
si
ty
/A
re
a 
(%
 o
f 
co
n
tr
o
l)
 
μM AlCl3 
* 
26 
 
 
Figure 9:  DA neuron degeneration significantly increases in WT animals with exposure to > 25 μM AlCl3.  
BY250 L1 worms were exposed for 30 min dH2O +/- μM AlCl3 and evaluated for DA neuron degeneration 
after 72 hr.  Shown are mean values + S.E.M.  Data was analyzed using one-way ANOVA followed by 
Dunnett’s multiple comparison test ***p < .001. 
 
In the mammalian brain the molecular basis of Al3+ transport is still unknown.  
Previous studies have suggested that Al3+ can interfere with iron homeostasis, and 
DMT1 has been shown to transport Fe2+into cells [99, 158, 159].  Therefore I 
hypothesized that one of the C. elegans homologues SMF-1, SMF-2, or SMF-3 may play a 
role in regulating Al3+ transport, and exposure may cause a significant change in gene or 
protein expression.  To determine whether Al3+ may affect smf-1, smf-2, or smf-3 gene 
expression, I exposed worms to 100 μM AlCl3 for 30 min and allowed them to recover 
on NGM plates for 48 hr.  A reduction of mRNA levels after exposure suggests that C. 
elegans DMT homologues, specifically SMF-2 and SMF-3 are highly sensitive to excess 
AlCl3 exposure and may be part of cellular response to limit Al
3+ accumulation (Figure 
10). 
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Figure 10:  Transcript levels of smf-2 and smf-3 decrease following acute Al
3+
 exposure.  L1 animals were 
exposed to 100 μM AlCl3 for 30 min and then allowed to recover for 48h on NGM plates  then mRNA was 
extracted, reverse-transcribed to cDNA, and relative gene expression changes of smf-1, smf-2, smf-3 were 
quantitated using qPCR. Fold change was calculated relative to GAPDH following the ΔΔCT method.  
Shown are mean values for fold change ± S.E.M. of three individual replicates.  * p < 0.05 between control 
and Al
3+
 treated group ΔCT values. 
 
Since SMF-1, SMF-2 [46] and SMF-3 are expressed in DA neurons (lab results, 
unpublished), acute exposure to Al3+ induces DA neuron degeneration, and Al3+ 
exposure elicits gene DMT1 homologue response, I tested the hypothesis that C. elegans 
SMF’s contribute to Al3+-induced DA neuron degeneration.  As mentioned before an 
assumed non-functional mutation in smf-3 significantly protects against Al3+-induced DA 
neuron cell death (Figure 11).  Since there was no change in  DA neuron degeneration  
after Al3+ exposure in strains containing mutations in either smf-1 or smf-2, the data 
suggests that these genes do not play a role in Al3+-induced DA neurodegeneration 
(Figure 11 A).  Similar results were seen with both WT and SMF-3 mutant animals 
exposed to 500 μM AlCl3 for 72 hrs. (data not shown).  All strains exposed to dH2O (WT, 
Δ smf-1, Δ smf-2, and Δ smf-3) did not exhibit DA CEP dendrite degeneration and 
therefore were not included in Figure 11 A. 
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Figure 11:  SMF-3 contributes to AlCl3-induced DA neuron degeneration in C. elegans.  L1 animals were 
exposed to dH2O + AlCl3 for 30 min and placed on NGM for evaluation after 72hr A) WT (BY250), Δ smf-1 
(RJ907), Δ smf-2 (RJ905), and Δ smf-3 (RJ906) respectively exposed to 100 μM AlCl3 for 30 min,  B) WT 
(BY250) and Δ smf-3 (RJ906) exposed dH2O + AlCl3 for 30 min. Data was analyzed using one-way ANOVA 
with a Dunnet post-test  (***p < .001) compared to WT at 100 μM AlCl3 (panel A) or using two-way 
ANOVA with Bonferroni post-test (**p < .01 or ***p < .001) compared to WT for each concentration 
tested (panel B). 
 
Al3+ exposure has been suggested to increase Fe2+ accumulation, as well as Fe2+-
induced oxidative injury [7, 159 - 161].  Iron-sulfur clusters are cofactors for aconitase 
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enzymes which are important for the isomerization of citrate to isocitrate in the Krebs 
cycle.  C. elegans has two aconitase genes, aco-1 which is cytosolic and a homolog to 
human iron regulatory protein-1.  While the cytosolic aconitase function is not known in 
C. elegans, aco-1 has been suggested to exhibit aconitase activity and be post-
translationally regulated by Fe2+ [162].  To determine if an aconitase linked Fe2+-
responsive pathway contributed to Al3+ neurotoxicity, I asked if aco-1 altered Al3+-
induced DA neuron degeneration.  A synchronized population of RNAi sensitive L1 
animals were exposed for 30 min dH2O +/- 100 μM AlCl3 and then allowed to recover on 
RNAi plates with bacteria expressing either empty vector or aco-1 dsRNA.  After a 72 
hour recovery, animals were evaluated for DA neuron degeneration.  Figure 12 suggests 
knock down of aco-1 increases Al3+-induced DA neuron degeneration, but verification of 
aco-1 knock down needs to be completed to confirm initial findings.   
  
Figure 12:  Knockdown of cellular aconitase aco-1 increases DA neuron degeneration after Al
3+
 exposure.  
RJ928 L1 animals were exposed for 30 min + 100 μM AlCl3 then allowed to recover on RNAi plates 
expressing HT115 or aco-1 dsRNA bacteria respectively for 72 hrs. and then degeneration determined.  
**p < .01 determined by t-test comparing the two Al
3+
 exposed groups.   
 
Brain glutathione has multiple functions including scavenging of highly reactive 
superoxide and hydroxyl radicals, and serving as a cofactor for a number of radical 
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scavenging enzymes such as glutathione peroxidase and glutathione s-transferases 
(GSTs) [95].  GSTs are part of a family of phase II detoxifying enzymes responsible for 
catalyzing the conjugation of the thiol group of reduced glutathione to electrophilic 
centers on a wide variety of substrates [163, 164].  An increase in ROS levels can induce 
GST expression that is involved in detoxification of exogenously and endogenously 
derived toxic compounds [142, 143].  In mammals, three of the seven classes of GSTs 
have been identified in the central nervous system and only GST pi class, specifically 
GSTP1, has been identified in dopaminergic neurons of the SN [88].  Prior studies have 
suggested toxic Al3+ exposure effects GSH enzyme activity [96, 97].  Since brief Al3+ 
exposure increases ROS through mitochondrial inhibition similar to results seen with 
Mn2+ exposure [46], I tested the hypothesis that gst-1 is also important in cellular 
response to Al3+ neurotoxicity.  To test this, RNAi sensitive animals were grown on either 
empty vector or gst-1 dsRNA bacteria.  A synchronized population of L1 animals were 
exposed to 100μM AlCl3 and then placed on the appropriate RNAi plates for 72hr to 
recover.  While knock down of gst-1 increased Al3+ included DA neuron degeneration, it 
was not significant compared to control (Figure 13).  gst-1 knock down was not verified, 
so one potential explanation for the results not producing further increased DA neuron 
sensitivity to Al3+ exposure as originally expected could be a result of in complete 
penetrance of RNAi knock down.  Assuming verification of knock down of gst-1 
produced statistically significant increased DA neuron degeneration, further 
experiments to determine gst-1 mRNA and/or protein response after AlCl3 exposure 
would help to determine if DA neuron degeneration correlates with gst-1 involvement 
in cellular response to AlCl3 induced DA neuron degeneration. 
 Overall these studies suggest that Al3+ toxicity in C. elegans increases oxidative 
stress through mitochondrial inhibition, and Al3+ exposure confers DA neuron 
degeneration.  These studies also show that Al3+-induced DA neurodegeneration is 
dependent on SMF-3 and suggests C. elegans aconitase aco-1 may contribute to the 
neuropathology. 
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Figure 13:  RNAi knockdown of gst-1 does not significantly increase DA neuron degeneration after Al
3+
 
exposure.  RJ928 L1 animals were exposed for 30 min dH2O + 100 μM AlCl3 then recovered on RNAi plates 
expressing HT115 or gst-1 dsRNA bacteria respectively for 72 hours prior to determination of 
degeneration. p=.18 as determined by t-test comparing the two Al
3+
 exposed groups. 
 
Copper 
While the molecular mechanisms for copper toxicity are largely unknown, free 
Cu2+ may be able to react with ROS and catalyze the production of highly toxic hydroxyl 
radical via Fenton reactions [20, 122].  Utilizing previous techniques [46], an hour after 1 
μM CuCl2 exposure whole animal ROS increased ~1.9 fold (Figure 14). 
Considering that an acute Cu2+ exposure increases whole animal ROS, I 
hypothesized that a brief Cu2+ exposure may also induce DA neuron degeneration.  As 
can be seen in Figure 15, a 30 min exposure in liquid culture to 1 - 50 μM CuCl2 
significantly increased the number of animals counted with DA neuron degeneration. 
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Figure 14:  30 min CuCl2 exposure significantly increases ROS levels in whole animals.  Whole animal ROS 
levels were measured following dH2O +/- 1 μM CuCl2 treatment for 30 min and incubation with DCF-DA 
for 60 min. ** p< .01 as determined by t-test compared to control. 
 
 
Figure 15:  Sub-lethal CuCl2 exposure significantly increases DA neuron degeneration.  BY250 L1 animals 
were exposed for 30 min to dH2O + 1 - 50 μM CuCl2 then examined 72 hr. later.  Concentrations 1-50 μM 
CuCl2 were determined significant (*** p< .001) by a Dunnett test following a one-way ANOVA . 
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Since Cu2+ transport is mediated by DMT1 or SMFs in mammals or yeast 
respectively, I asked if any of  the SMF’s are able to mediate Cu2+-induced DA neuron 
degeneration.  A synchronized population of L1s for WT along with each of the non-
functional SMF mutant strains was exposed for 30 min to 1 μM CuCl2 and degeneration 
determined 72 hrs. later.  I found that C. elegans smf-2, but not smf-1 or smf-3 is 
involved in Cu2+-induced DA neuron degeneration (Figure 16).  All strains exposed to 
dH2O (WT, Δ smf-1, Δ smf-2, and Δ smf-3) did not exhibit DA CEP dendrite degeneration 
and therefore were not included in Figure 16 A. 
Nass et al. 2002 previously established 6-OHDA as a PD model for inducing DA 
neuron degeneration in C. elegans and showed that mutations in dat-1 was able to 
protect against 6-OHDA induced DA neuron degeneration.  Additional studies have 
shown that Cu2+ can accelerate autoxidation of DA in addition to increasing 6-OHDA 
induced oxidative stress such as DNA damage and mitochondrial dysfunction [105 - 107, 
167].  Also, in vitro studies have suggested that copper and dopamine can form a 
complex which is specifically transported by DAT [167 - 169].  To test the hypothesis that 
Cu2+-induced DA neuron degeneration may be dependent on DAT, I utilized the BY215 
strain (referred to as Δdat-1 in the figure) that has a functional knockout of DAT and 
expresses GFP in the DA neurons Pdat-1::GFP;rol-6;dat-1(ok157)III [38].  BY215 was 
generated from the background strain BY200, Pdat-1::GFP; rol-6,  and therefore BY215 
was used as the control strain.  A synchronized population of L1 animals were exposed 
for 30min to dH2O + 1 or 100 μM CuCl2 and placed on plates to recover for 72hrs.  As 
can be seen in Figure 17, Cu2+-induced DA neuron cell death appears to be dependent 
on DAT. 
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Figure 16:  SMF-2 significantly contributes to CuCl2-induced DA neuron degeneration in C. elegans.  L1 
animals were exposed to dH2O + CuCl2 for 30 min and placed on NGM for evaluation after 72hr A) WT 
(BY250), Δ smf-1 (RJ907), Δ smf-2 (RJ905), and Δ smf-3 (RJ906) respectively exposed to 1 μM CuCl2,  B) WT 
(BY250) and Δ smf-2 (RJ905) exposed dH2O + CuCl2.  Data was analyzed using one-way ANOVA with 
Dunnett post-test (*p < .05) compared to WT (panel A) or two-way ANOVA with Bonferroni post-test 
(***p < .001) compared to WT for each concentration tested (panel B). 
 
50
55
60
65
70
75
80
85
90
95
100
N
o
rm
al
 C
EP
 d
e
n
d
ri
te
s 
(%
 w
o
rm
s)
 
50
55
60
65
70
75
80
85
90
95
100
0 1 25 50
N
o
rm
al
 C
EP
 d
e
n
d
ri
te
s 
(%
 w
o
rm
s)
 
μM CuCl2 
WT ∆ smf-2 
*** ** 
* 
1 μM CuCl2 
A 
B 
*** 
35 
 
  
Figure 17:  DAT-1 contributes to Cu
2+
-induced DA neuron degeneration.  Strains BY200 (WT) and BY215 
(Δdat-1) respectively were exposed for 30min and degeneration evaluated after 72h.  Data was analyzed 
using two-way ANOVA with Bonferroni post-test (***p < .001) compared to WT at each concentration.  
 
In summary low level CuCl2 exposure increases both whole animal ROS and DA 
neuron cell death.  My data also indicates that Cu2+-induced DA neuron degeneration is 
dependent both on DAT-1 and SMF-2. 
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Discussion and Future Direction: 
While the etiologies of many neurodegenerative diseases are still unknown, 
epidemiological data has suggested that most of the pathologies develop from a 
combination of both genetic and environmental risk factors.  A number of studies have 
shown environmental metal exposure increases cell death that is characteristic of 
neurodegenerative disorders such as AD, PD, Wilson’s disease and Menkes disease.  
Mounting evidence collected from post mortem patients suggests metal exposure can 
decrease neurodegenerative disease age of onset [29, 30, 33, 148, 149].  High oxygen 
consumption rate, membranes enriched in oxidizable polyunsaturated fatty acids, lower 
antioxidant enzyme activity, DA catabolism, and large stores of Fe2+ have been 
suggested as factors contributing to DA neuron-associated disorders [29, 85 - 87].  For 
example, loss of dopamine neurons in the substantia nigra is a hallmark of PD and Mn2+-
induced neurotoxicity, and mitochondrial dysfunction has been implicated in disease 
progression.  In these studies, I utilized C. elegans translational GFP fusions to view DA 
neurons in vivo and identify metals that contribute to DA neuron cell death and 
oxidative stress.  These studies suggest that C. elegans DA neurons are sensitive to Mn2+, 
Fe2+, Al3+, and Cu2+.  The loss of CEP dendritic GFP seen in my experiments is similar to 
prior studies from our lab after exposure to Mn2+ or 6-OHDA, which correlated loss of 
GFP in toxicant exposed animals with a loss of total animal DA concentration and loss of 
neuronal integrity by electron microscopy [38, 46].  High performance liquid 
chromatography coupled to an electrochemical detection system determined 
approximately 60% loss of DA in animals exposed to Mn2+ as compared with control 
animals, which is consistent with DA neuronal loss [46].  Also my experiments show that 
the C. elegans transporters SMF-1 SMF-2, and SMF-3 contribute significantly to Fe2+, 
Cu2+, and Al3+-induced DA neuron degeneration respectively.  Furthermore, I show that 
DAT plays a role in Cu2+-induced DA neuronal death. These studies provide insight into 
potential molecular pathways involved in neurodegenerative disease progression. 
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Aluminum 
Exposure to high concentrations of Al3+ confers cell death in many organisms 
[155, 156].  Al3+ is not a redox-active metal, yet has been shown to facilitate Fe2+-
induced oxidative stress and inhibit multiple antioxidant enzymes [73, 96 - 100, 174].  
Our laboratory previously determined Mn2+ exposed animals exhibit an approximate 
15% reduction in TMRE intensity in the head region of the animals and also showed a 
greater than 2 fold reduction of cellular oxygen consumption, which has been correlated 
with dysfunctional mitochondria in both vertebrates and C. elegans [46].  I found that a 
30 min exposure of C. elegans to sub-lethal concentrations of AlCl3 significantly 
decreased TMRE intensity in the head region of animals (Figure 8), consistent with prior 
studies, and suggests Al3+ impairs mitochondria function [76, 175].  Elevated cellular 
levels of Al3+ have been reported in multiple neurodegenerative diseases including AD, 
parkinsonism-dementia of Guam, and ALS [7 - 10, 31, 146].  Al3+ has also been shown to 
alter neurotransmission by binding negatively charged lipids to alter membrane 
integrity, alter dopamine receptor density, and decrease dopamine levels [73, 75, 76].  
In addition, Al3+ has been shown to exacerbate both MPTP and 6-OHDA induced DA 
neuron degeneration in animal models of PD [96, 104, 176].  My studies show that 
animals subjected to either chronic (72 hr.) or brief (30 min) exposure of sub-lethal 
levels of AlCl3 exhibit significantly increased DA neuron degeneration (Figures 6 C & 9 
respectively).  Additional studies from our lab have verified that this Al3+-induced 
neuron degeneration is specific to DA neurons (manuscript in progress).  Taken 
together, this data recapitulates vertebrate studies suggesting Al3+ exposure increases 
oxidative stress and DA neuron vulnerability in C. elegans.  
Al3+ has a small ionic radius and high charge and has been shown to have similar 
inorganic chemistry to Fe3+ [177].  The molecular basis for Al3+ transport across cell 
membranes in mammals is unknown, but it has been suggested that transferrin receptor 
mediated endocytosis or glutamate transporter uptake of an Al3+-citrate complex may 
play a role [7].  A few studies have suggested Al3+ can interfere with iron homeostasis 
[99, 158, 159].  The vertebrate Fe2+ transporter DMT1 has been shown to play a role in 
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iron uptake system [84, 161].  To determine whether C. elegans DMT1 homologues may 
contribute to AlCl3 toxicity, I determined changes in gene expression following a 30 min 
exposure to sub-lethal AlCl3.  I found that smf-2 and smf-3 are significantly down 
regulated following the exposure (Figure 10), suggesting they may be down-regulated in 
order to limit cellular Al3+ accumulation.  While there are limited studies available, SMF 
expression patterns in C. elegans suggest that SMF-1 is localized to DA neurons [46] and 
is primarily expressed in the intestine and associated gland cells with faint expression 
observed in a subset of anterior sensory neurons, ring neurons, and posterior-head 
neurons [150,151].  Expression of SMF-2 has been identified in DA neurons [46], 
epithelial cells of pharynx, and pharyngeal-intestinal valve cells [150].  Expression of 
SMF-3 has been identified in DA neurons (our lab unpublished data), along the intestine, 
and a weak expression in head and tail neurons [150, 151].  I then evaluated strains with 
mutations in SMF, as they have been shown to be localized to DA neurons, to determine 
whether they played a role in Al3+-induced DA neuron degeneration.  I found that SMF-3 
contributes to Al3+-induced DA neuron degeneration (Figure 11).  Since my original 
experiments, other experiments from our lab using RNAi to knock down gene 
expression of both smf-1 and smf-2 simultaneously, also confirmed that expression of 
smf-3 contributes to Al3+-induced DA neuronal death.  SMF-3 expression seems to be 
important specifically in Al3+-induced DA neuron degeneration, as there was no 
significant change in the number of animals observed with DA neuron degeneration in 
smf-3 mutant animals after exposure to MnCl2, FeCl2, and CuCl2 ([46] and Figures 7B & 
16A).  To the best of my knowledge there was not any priore data suggesting that a 
trivalent ion such as Al3+ can be transported by DMT 1.  It had been proposed that Al3+ 
might interact with an unknown protein to alter DMT 1 functionality as an explaination 
for the altered Fe2+ accumulation [161].  A recent study by Xia J. et al. 2010 identified an 
Al3+ specific rice plasma membrane transporter, Nrat1, which is highly homologous to 
DMT1.  To determine if Nrat1 is homologous to SMF-3, a BLAST search with the SMF-3 
and rice transporter and a sequence alignment of the results using ClustalW2 indicates 
that SMF-3 has approximately a 36% amino acid identity and a 55% similarity to the rice 
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transporter (Figure 18).  Nrat1 shows similar sequence characteristics with the identified 
DMT-1 consensus transport sequence and the 12 transmembrane spanning domains.  
These results suggest that SMF-3 may facilitate Al3+ transport across the plasma 
membrane and confer both animal and DA vulnerability to the metal.  
 
DMT-1_H.sapiens      ------------------------------------------------------------ 
SMF1_C.elegans       ------------------------------------------------------------ 
SMF2_C.elegans       ------------------------------------------------------------ 
SMF-3_C.elegans      MPRVHRQSRWNSVSFSGFFLQISGIKPRFTSEKGSFLKKKLILKIRFFFKIFFADKTMNF 60 
Nrat1_O.sativa       ------------------------------------------------------------ 
                                                                                  
 
DMT-1_H.sapiens      -----------MVLGPEQKMSDDSVSG---------DHGESASLGNINPAYSNPSLSQSP 40 
SMF1_C.elegans       ---------------MASSNNDGPIEP--------EAEPWR---ITQNDHLEQDLLEEDA 34 
SMF2_C.elegans       ------------MSPTVTCICCCPLSS--------ENAWFSKRHISSSPGSRKNVHDCSK 40 
SMF-3_C.elegans      LIFIFDALTFFISKNTVDTVNFAIFVPNFLIVFFSKFKNFSDNILTMEGEMKCPIEEIRE 120 
Nrat1_O.sativa       ----------MEGTGEMREVGRETLHG------------GVVQSVSETDEYKEKTIDSEK 38 
                                             .                    .          .    
 
DMT-1_H.sapiens      GDSEEYFATYFNEKISIPEEEYS-CFSFRKLWAFTGPGFLMSIAYLDPGNIESDLQSGAV 99 
SMF1_C.elegans       ESQ---------ERVDIPVDDVEKAFSFKKLWAFTGPGFLMSIAYLDPGNIESDLQSGAQ 85 
SMF2_C.elegans       NSRRKGIILNQAKQISVCINAQNTWFSWRKLWAFTGPGFLMSIAYLDPGNIESDLQAGAQ 100 
SMF-3_C.elegans      KPEMRKAQQTYEVQVEV-EDTPDTTFSWRKLWAFTGPGFLMSIAYLDPGNIESDLQAGAI 179 
Nrat1_O.sativa       DGQ------------------FRVQPRWRKFLAHVGPGALVAIGFLDPSNLETDMQAGAD 80 
                                                ::*: *..*** *::*.:***.*:*:*:*:**  
 
DMT-1_H.sapiens      AGFKLLWILLLATLVGLLLQRLAARLGVVTGLHLAEVCHRQYPKVPRVILWLMVELAIIG 159 
SMF1_C.elegans       AAYKLLWVLLSAHIIGMLLQRMSARLGVVSGKHMAEVAYQFYPRLPRIILWLMIEIAIVC 145 
SMF2_C.elegans       AEYKLLWVLLVSHIVGMLLQRMSARLGVVSGKHMAEIAYDYYPLVPRIILWLMIEIAIVC 160 
SMF-3_C.elegans      SYFKLIWVLLVAHIMGLLLQRLAARLGVVSGKHMAEIAFSYYPKIPRLVLWMLVESAIVG 239 
Nrat1_O.sativa       FKYELLWVILVGMVFALLIQTLAANLGVKTGRHLAELCREEYPHYVNIFLWIIAELAVIS 140 
                       ::*:*::* . :..:*:* ::*.*** :* *:**:.   **   .:.**:: * *::  
 
DMT-1_H.sapiens      SDMQEVIGSAIAINLLSVGRIPLWGGVLITIADTFVFLFLDKYGLRKLEAFFGFLITIMA 219 
SMF1_C.elegans       SDMQEVIGTAIAIFLLSKGFVPLYVGVFITILDTFTFLLIDRYGIRKLELIFGFLILTMT 205 
SMF2_C.elegans       SDMQEVIGTAIAIYLLSSGKIPLLVGVLITILDTFTFLFIDRYGIRKLEFIFVALISTMA 220 
SMF-3_C.elegans      SDMQEVIGTAISFYLLSNGVIPLWAGVLITICDTFTFLFLEKYGVRKFEAFFCFLITCMA 299 
Nrat1_O.sativa       DDIPEVLGTAFAFNILLK--IPVWAGVILTVFSTLLLLGVQRFGARKLEFIIAAFMFTMA 198 
                     .*: **:*:*::: :*    :*:  **::*: .*: :* ::::* **:* ::  ::  *: 
 
DMT-1_H.sapiens      LTFGYEYVTVKPSQSQVLKGMFVPSCSGCRTPQIEQAVGIVGAVIMPHNMYLHSALVKSR 279 
SMF1_C.elegans       VSFGYEFVVVKPPIGEVISGMVVPWCAGCGKGEFMQAISVVGAVIMPHNLYLHSALVKSR 265 
SMF2_C.elegans       ISFGYEFVVMKPVLTKVLTGTVVPWCSGCGKEEIITAISIFGAVIMPHNFYLHSALVKSR 280 
SMF-3_C.elegans      ITFGYEFGVSAPDAGKMFSGMFVPWCNGCDNNMVMQGVAIIGAVIMPHNFYLHSALVKSR 359 
Nrat1_O.sativa       ACFFGELSYLRPSAGEVVKGMFVPSLQ--GKGAAANAIALFGAIITPYNLFLHSALVLSR 256 
                       *  *     *   ::..* .**      .     .:.:.**:* *:*::****** ** 
 
DMT-1_H.sapiens      QVNRNNKQEVREANKYFFIESCIALFVSFIINVFVVSVFAEAFFGKTNEQVVEVCTNTSS 339 
SMF1_C.elegans       RVDRKDRRRVAEANKYFTLESAIALFLSFFINLFVVAVFAHGLYQKTNADVREMCIARHD 325 
SMF2_C.elegans       KVDRSSKTRIAEANKYFSIESAFALSVSFFINLFVLSVFARGLYQKTNGDV--------- 331 
SMF-3_C.elegans      RVDRRRAEKVTEANKYFFIESAFALFVSFIINTLVISVFAQGMYGKTNQDIRDTCYNNTH 419 
Nrat1_O.sativa       KTPRSDKS-IRAACRYFLIECSLAFIVAFLINVSVVVVAGSICNANNLSPADANTCG--- 312 
                     :. *     :  * :** :*..:*: ::*:**  *: * .     :.              
 
DMT-1_H.sapiens      P-----HAGLFPKDNSTLAVDIYKGGVVLGCYFGPAALYIWAVGILAAGQSSTMTGTYSG 394 
SMF1_C.elegans       I----PDADIFPNNTEPVEVDIYKGGIYLGCQFGAIAMFIWGIGIFAAGQSSTMTGTYTG 381 
SMF2_C.elegans       ------------------------GGIYLGCQFGLFAMIIWAIGIFAAGQSSTMTGTYTG 367 
SMF-3_C.elegans      NGMPDFYKVEFPANNDAAQSDIYHAGIFLGCTFGIFALYVWAVGILAAGQSSTMTGTYAG 479 
Nrat1_O.sativa       ------------------DLTLQSTPLLLRNVLGRSSSVVYAVALLASGQSTTISCTFAG 354 
                                               : *   :*  :  ::.:.::*:***:*:: *::* 
 
DMT-1_H.sapiens      QFVMEGFLNLKWSRFARVVLTRSIAIIPTLLVAVFQD-VEHLTGMNDFLNVLQSLQLPFA 453 
SMF1_C.elegans       QFVMEGFVKIEWPKWKRVLITRAIAITPTLVLTFYSQGVQNLTGMNDFLNCVQMIQLPFA 441 
SMF2_C.elegans       QFVMEGFVRISWPKWKRVLITRAVAITPTLILCIKAHGIKNLTGMNDFLNCVQMVQLPFA 427 
SMF-3_C.elegans      QFAMEGFIQIKLPQWKRILITRSLAILPTLAVVIFSGGIDNISSLNDFLNCLQLIQLPFA 539 
Nrat1_O.sativa       QVIMQGFLDMKMKNWVRNLITRVIAIAPSLIVSIVSG-PSGAGKLIILSSMILSFELPFA 413 
                     *. *:**: :.  .: * ::** :** *:* : .     .    :  : . :  .:**** 
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DMT-1_H.sapiens      LIPILTFTSLRPVMSDFANGLGWRIAGGILVLIICSINMYFVVVYVRD-LG--------H 504 
SMF1_C.elegans       LIPIITFTSSRKIMHDFRSSKVFQIFALITSALILSINVYFISDYVFSRLGS-------E 494 
SMF2_C.elegans       LIPMITFTSSKRIMHNFRTSKPLQYFSIICGIITIGINVYFIFQYVTENFGT-------G 480 
SMF-3_C.elegans      LIPVLTFVSDRNIMHEYKLASVSKVVSIVISLIILFINFYFLYSWIGSTFGY-------N 592 
Nrat1_O.sativa       LIPLLKFCNSSKKVGPLKESIYTVVIAWILSFALIVVNTYFLVWTYVDWLVHNNLPKYAN 473 
                     ***::.* .    :     .      . :       :* **:     . :           
 
DMT-1_H.sapiens      VALYVVAAVVSVAYLGFVFYLGWQCLIA--------LGMSFLDCGHTVSISKGLLTEEAT 556 
SMF1_C.elegans       WYIIMVLAPITFAYVLFVLYLALYCLVSCEIIPD-TVSIRGFSFNKSYENDAPWLAVDSS 553 
SMF2_C.elegans       WLIFVIIGPFTLLYIAFILYLAIYCLVACELMND-TVNLPGFDFHRTLELDAPWITET-- 537 
SMF-3_C.elegans      AVSIPITIFCAIFYIIFIAYLTYYCLVAMEFIS--PIQTKWLAEPIYHDFDAPWLEDSEN 650 
Nrat1_O.sativa       GLISVVVFALMAAYLVAVVYLTFRKDTVATYVPVPERAQAQVEAGGTPVVDASAADEDQP 533 
                          :       *:  : **                    .        .          
 
DMT-1_H.sapiens      RGYVK----------- 561 
SMF1_C.elegans       AVHDNAGYQ------- 562 
SMF2_C.elegans       FVVNDVYF-------- 545 
SMF-3_C.elegans      PSTKNTISDDELSMRY 666 
Nrat1_O.sativa       APYRKDLADASM---- 545 
 
Figure 18:  Sequence alignment of rice Nrat1 Al
3+
 specific transporter with C. elegans and human DMTs.  
The sequences of human DMT-1 (GenBank accession number NP_000608), C. elegans SMF-1 (GenBank 
accession number AAC465690, C. elegans SMF-2 (GenBank accession number AAC46568), C. elegans SMF-
3 (GenBank accession number AAL27264), and O. sativa Nrat1 (GenBank accession number 
NP_001045794) were aligned using the ClustalW2 program following an NCBI Blast search.  The 
characteristic 12 transmembrane domains of DMT-1 are highlighted in black, and the consensus transport 
sequence is located between transmembrane domains 8 and 9 is highlighted in yellow.  The red font in the 
sequence represents hydrophobic amino acids, whereas blue represents acidic, magenta represents basic, 
and green represents hydroxyl.  The asterisk indicates amino acids in that column are identical, colons 
represent conserved substitutions (same color group), and periods represent semi-conserved 
substitutions (similar shapes).   
 
Iron-sulfur clusters are cofactors for aconitase enzymes that are important for 
the isomerization of citrate to isocitrate in the Krebs Cycle.  Aconitases are found in the 
cytosol, mitochondria, and glyoxysomes and have been shown to alter activity based on 
changes in iron availability [162].  I found that C. elegans homologue to cytosolic 
aconitase/iron regulatory protein-1, aco-1, plays a role in Al3+ induced DA neuron 
degeneration.  RNAi knock down of aco-1, increases DA neuron degeneration after a 30 
min exposure to AlCl3 (Figure 12).  These results are consistent with prior studies 
suggesting that Al3+ exposure may increase free Fe2+ due to the lack of cytosolic 
aconitase and may be a contributing factor to DA neuron cell death.  As only two 
experiments were performed, it would be important to determine degeneration from at 
least one more group to ensure statistical significance.  It would also be important to 
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determine if the mitochondrial aconitase, identified in C. elegans as aco-2, is also 
playing a role in the neuropathology particularly since Al3+has been shown to be a 
potent mitochondrial toxicant.  Ferritin’s main function is to provide bioavailable, but 
non-toxic storage of iron [178].  A few studies have suggested that after Al3+ exposure 
Fe2+ incorporation into ferritin changes, potentially suggesting ferritin may act as an 
aluminum detoxicant [161, 179].  My preliminary studies using RNAi to knock down 
either ferritin gene ftn-1 or ftn-2 do not show significant changes in DA neuron 
degeneration after exposure to 100 μM AlCl3, but RNAi knock down was not confirmed, 
these studies were only performed in duplicate, and both ferritin genes were not 
knocked down in combination.  Knock down of both genes simultaneously would 
eliminate potential protective compensatory effects.   
Overall my results are consistent with prior studies suggesting that Al3+ increases 
oxidative stress in vivo.  My studies also show that SMF-3 contributes to Al3+-induced DA 
neuron degeneration, and knock down of C. elegans aconitase aco-1 increases DA 
neuron sensitivity to Al3+.  Further experiments to measure SMF transport of Al3+ and 
dissection of the Fe2+ regulatory pathways may lead to an understanding of how SMF-3, 
whether direct or indirect, plays a role in Al3+ induced DA neuron degeneration. 
 
Copper 
Cu2+ is an essential metal ion and its dysregulation has been implicated in the 
promotion of oxidative stress and the development of neurodegenerative diseases.  
Cu2+’s ability to donate or accept electrons facilitates the Fenton or Haber-Weiss 
reaction and produces highly reactive superoxide and hydroxyl radicals that may play a 
role in Cu2+-induced DA neuron degeneration [16, 20, 106, 166].  Consistent with 
vertebrate studies, I found that exposure of C. elegans to sub-lethal CuCl2 
concentrations increases whole animal ROS (Figure 13).  I also found that both chronic 
(72 hr.) and short term (30 min) exposure to CuCl2 increases DA neuron degeneration 
(Figure 6 D & 15 respectively).  Similarly after 30 min exposure in liquid, concentrations 
above 50 μM Cu2+ resulted in large numbers of animal death in addition to delayed 
42 
 
development.  One potential hypothesis for this narrow range of toxicant concentration 
could be explained by the fact that excess copper is toxic, and while DA neurons are 
clearly sensitive to copper exposure, the exposure of the whole worm overrides other 
essential copper regulatory mechanisms at concentrations higher than 50 μM in my 
experimental paradigm.  In a preliminary experiment I looked at GABAergic neurons 
after brief 1 μM CuCl2 and did not find any significant change in GFP expression as I 
expected, but to verify Cu2+-induced degeneration was DA neuron specific further 
experiments would need to be conducted. 
DMT1 is known to transport Cu2+ in vertebrates, and may play a role in increased 
cellular free Cu2+.  I found that C. elegans DMT1 homologue SMF-2 plays a role in CuCl2-
induced DA neurodegeneration (Figure 16).  SMF-2 localization to DA neurons in C. 
elegans [46] suggests that SMF-2 may transport Cu2+ into the DA neurons or into a Cu2+ 
sensitive intracellular compartment. 
The neurotoxicant 6-OHDA has been shown to confer DA neuron degeneration, 
and rapidly oxidize to produce hydrogen peroxide, hydroxyl radicals and quinones [185, 
186].  Vertebrate studies incorporating 6-OHDA have shown increased Cu2+ 
accumulation in dopaminergic pathways, and co-exposure with Cu2+ accelerates 
autoxidation of DA and production of its metabolites [105 - 107].  Prior studies have 
found DMT1 isoforms upregulated in the SN of PD patients, and DMT1 has been 
implicated in transport of the excess Fe2+ capable of catalyzing deleterious Fenton 
reactions after 6-OHDA or MPTP exposure [84, 112, 114].  Previous studies have also 
implicated DAT in Cu2+-induced cell death [167].  Here I show that DAT also contributes 
to DA neuron vulnerability in C. elegans as a functional knockout of DAT protects the DA 
neurons from Cu2+-induced pathology (Figure 17).  Previous studies by Nass et al. 2002 
show that a DAT deletion or inhibition with imipramine inhibits 6-OHDA-induced DA 
neurodegeneration.  Taken as a whole my studies suggest that 6-OHDA and Cu2+ may 
share a common pathway to increased DA neuron pathology.   
In vitro studies have suggested that Cu2+ and DA are able to form a complex that 
is transported by DAT [167 - 169].  Considering that both 6-OHDA and DA are easily 
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oxidized in the presence of Cu2+, it may be possible that SMF-1 or SMF-2 may indirectly 
influence DA-associated proteins or DA metabolism to alter DA neuron degeneration.  6-
OHDA treated cells have shown increased levels of DMT-1 along with increased iron 
influx.  Also changes in free intracellular Fe2+ have been shown to affect DAT expression 
levels [84, 187].  Furthermore a reduction of DAT expression or function in the SMF 
mutant animals could result in lower accumulation of neurotoxicants attributing to 
neuron resistance [46].  Therefore it would be important to determine whether 
functional knockdown of any of the SMFs may modulate DAT-1 expression or function.   
A Cu+-GSH2 complex has been previously reported to accumulate in the cell after 
copper exposure [102].  This complex has been shown to reduce cellular Fe3+ levels as 
well as releasing it from ferritin [102, 188].  This reaction would cause an increase in the 
intracellular free Fe2+ pool that in turn may increase the cell’s ROS levels through Fenton 
chemistry or modulate SMF or DAT expression (Figure 19).  If Fe2+ is playing a role in 
regulation of DAT-1, SMF-1, SMF-2, or both, it would be important to determine 
changes in ferritin (FTN-1/FTN-2) expression and Fe2+ concentrations after Cu2+ 
exposure. 
In summary, excess Cu2+ may indirectly regulate DAT through a SMF pathway 
responsible for maintaining divalent metal ion homeostasis or directly based on changes 
in oxidative stress.  Further studies examining DAT expression changes in association 
with SMF, Fe2+, and oxidative stress pathways will assist in elucidating the mechanisms 
involved in Cu2+-induced DA neuron degeneration. 
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Figure 19:  Potential mechanism of Cu
2+
-induced DA neuron degeneration.  SMF-2 plays a role in Cu
2+
 and 
6-OHDA induced DA neuron cell death, SMF-1 plays a role in 6-OHDA induced DA neuron cell death, and 
DAT-1 inhibits Cu
2+
induced cell death.  Therefore potential mechanisms are: 1) Cu-DA complex 
transported by DAT-1 introduces neurotoxic quione radicals which facilitate increased ROS and 
degradation of SMF-1 and SMF-2 to prevent further accumulation of Cu
2+
 or other divalent metal ions 2) 
SMF-2 plays a role in regulation of DAT-1 expression or function due to changes in free Fe
2+
, similar to in 
vitro data showing decreased intracellular free Fe
2+
 decreases DAT-1 expression, thereby limiting Cu
2+
 
induced DA neuron cell death.  GSH, glutathione; ROS, reactive oxygen species; FTN, ferritin; DA, 
dopamine; CUC-1, copper chaperone; CUA-1, copper ATPase; DAT-1, dopamine transporter. 
 
Conclusion 
DMT1 and its homologues have been shown to transport divalent cations in a 
number of eukaryotes [14, 109, 110].  DMT-1 has also been implicated in the 
development of PD, and it has been suggested that its regulation may contribute to 
dysfunctional metal homeostasis leading to increased neuronal stress and cell death.  
Our lab previously identified three putative C. elegans homologues to human DMT1, 
SMF-1, SMF-2, and SMF-3 and determined that they are expressed in C. elegans DA 
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neurons [46, unpublished data].  Here I demonstrate that SMF-1, SMF-2, and SMF-3 play 
specific roles in divalent metal ion-induced DA neurodegeneration.  I show that SMF-1 
contributes to Fe2+-induced DA neuron death, and SMF-2 and DAT-1 contribute to Cu2+-
induced DA neuron vulnerability.  In addition my studies show that SMF-3 contributes to 
trivalent Al3+-induced cell death. 
These studies suggest that inhibition of Mn2+, Fe2+, Al3+ or Cu2+ dysregulation 
may limit oxidative stress and decrease DA neuron degeneration.  C. elegans provides a 
unique and powerful model to evaluate and characterize molecules and pathways 
involved in metal toxicity, and may identify novel therapeutic targets that are involved 
in metal-induced DA neuron degeneration and PD. 
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